"Insulin-Secreting Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A type of pancreatic cell representing about 50-80% of the islet cells. Beta cells secrete INSULIN.
| Descriptor ID |
D050417
|
| MeSH Number(s) |
A03.734.414.131 A06.390.131 A06.407.414.087 A11.382.625.092 A11.436.294.092
|
| Concept/Terms |
Insulin-Secreting Cells- Insulin-Secreting Cells
- Cell, Insulin-Secreting
- Cells, Insulin-Secreting
- Insulin Secreting Cells
- Insulin-Secreting Cell
- beta Cells, Pancreatic
- Pancreatic beta Cell
- beta Cell, Pancreatic
- Pancreatic B Cells
- B Cell, Pancreatic
- B Cells, Pancreatic
- Pancreatic B Cell
- Pancreatic beta Cells
|
Below are MeSH descriptors whose meaning is more general than "Insulin-Secreting Cells".
Below are MeSH descriptors whose meaning is more specific than "Insulin-Secreting Cells".
This graph shows the total number of publications written about "Insulin-Secreting Cells" by people in this website by year, and whether "Insulin-Secreting Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 2 | 3 |
| 2008 | 4 | 1 | 5 |
| 2009 | 0 | 2 | 2 |
| 2010 | 2 | 0 | 2 |
| 2011 | 4 | 2 | 6 |
| 2012 | 8 | 2 | 10 |
| 2013 | 5 | 1 | 6 |
| 2014 | 3 | 1 | 4 |
| 2015 | 5 | 2 | 7 |
| 2016 | 2 | 3 | 5 |
| 2017 | 2 | 1 | 3 |
| 2018 | 4 | 0 | 4 |
| 2019 | 5 | 4 | 9 |
| 2020 | 4 | 2 | 6 |
| 2021 | 3 | 1 | 4 |
| 2022 | 4 | 0 | 4 |
| 2023 | 1 | 0 | 1 |
| 2024 | 3 | 1 | 4 |
| 2025 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Insulin-Secreting Cells" by people in Profiles.
-
Differential Treatment Effects on ?-Cell Function Using Model-Based Parameters in Type 2 Diabetes: Results From the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes Care. 2025 Apr 01; 48(4):623-631.
-
Pancreatic organogenesis mapped through space and time. Exp Mol Med. 2025 Feb; 57(1):204-220.
-
SPOCK2 controls the proliferation and function of immature pancreatic ?-cells through MMP2. Exp Mol Med. 2025 Feb; 57(1):131-150.
-
ISPAD Clinical Practice Consensus Guidelines 2024: Screening, Staging, and Strategies to Preserve Beta-Cell Function in Children and Adolescents with Type 1 Diabetes. Horm Res Paediatr. 2024; 97(6):529-545.
-
Multiple beta cell-independent mechanisms drive hypoglycemia in Timothy syndrome. Nat Commun. 2024 10 17; 15(1):8980.
-
High Prevalence of A-?+ Ketosis-Prone Diabetes in Children with Type 2 Diabetes and Diabetic Ketoacidosis at Diagnosis: Evidence from the Rare and Atypical Diabetes Network (RADIANT). Pediatr Diabetes. 2024; 2024.
-
Osteocalcin protects islet identity in low-density lipoprotein receptor knockout mice on high-fat diet. J Endocrinol. 2024 Apr 01; 261(1).
-
Type 1 Diabetes Genetic Risk Score Differentiates Subgroups of Ketosis-Prone Diabetes. Diabetes Care. 2023 10 01; 46(10):1778-1782.
-
Maladaptive positive feedback production of ChREBP? underlies glucotoxic ?-cell failure. Nat Commun. 2022 07 30; 13(1):4423.
-
The Chd4 subunit of the NuRD complex regulates Pdx1-controlled genes involved in ?-cell function. J Mol Endocrinol. 2022 06 14; 69(2):329-341.